CEO Dave Ricks says Lilly’s weight loss pill, or foragliprone, could get FDA approval in 2026
Eli Lilly & Co., the Fortune 500 pharma firm that makes the weight-loss injection Zepbound (tirzepetide), has a comparable oral ...
Read more
4 reasons to buy the dip after the 17% decline
Eli Lilly and Company today LLI Eli Lilly and Company $797.17 -2.73 (-0.34%) 01/13/2025 to 03:58 PM Eastern 52-week range ...
Read more
PACCAR, Lilly, Mastercard Boost Payouts
These three stocks, which are at or near the top of their respective industries, have only increased dividends by double-digit ...
Read more
Lilly-funded clinical trial says Zapbound (tirzepetide) superior to Vegovi (semaglutide)
In the midst of the war on obesity, a battle between two weight loss vaccines has emerged as a clear ...
Read more
